KEITH WEBSTER to Angiogenesis Inhibitors
This is a "connection" page, showing publications KEITH WEBSTER has written about Angiogenesis Inhibitors.
Connection Strength
0.403
-
Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy. Int J Mol Sci. 2024 Sep 01; 25(17).
Score: 0.189
-
Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. Cell Mol Life Sci. 2022 Jan 10; 79(1):63.
Score: 0.157
-
Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization. Biomolecules. 2024 Feb 21; 14(3).
Score: 0.045
-
Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein. Mol Cancer Ther. 2005 Jun; 4(6):956-67.
Score: 0.012